tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CMMB Stock Latest News

Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Press ReleasesChemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
6d ago
CMMB
Chemomab Therapeutics reports publication on its CCL24 target, SSc
PremiumThe Fly
Chemomab Therapeutics reports publication on its CCL24 target, SSc
6d ago
CMMB
Chemomab Therapeutics to hold a conference call
PremiumThe Fly
Chemomab Therapeutics to hold a conference call
14d ago
CMMB
Chemomab Therapeutics to hold a conference call
PremiumThe Fly
Chemomab Therapeutics to hold a conference call
14d ago
CMMB
Chemomab Therapeutics to hold a conference call
PremiumThe Fly
Chemomab Therapeutics to hold a conference call
14d ago
CMMB
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
PremiumPress ReleasesChemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
22d ago
CMMB
Chemomab Therapeutics awarded European patent for CM-101
PremiumThe Fly
Chemomab Therapeutics awarded European patent for CM-101
30d ago
CMMB
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
PremiumPress Releases
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
30d ago
CMMB
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update
PremiumPress Releases
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update
2M ago
CMMB
CMMB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CMMB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CMMB
Chemomab Therapeutics awarded new patents for CM-101 in Brazil and Israel
PremiumThe Fly
Chemomab Therapeutics awarded new patents for CM-101 in Brazil and Israel
2M ago
CMMB
Chemomab Therapeutics’ CM-101 shows clinical potential in sclerosing cholangitis
PremiumThe Fly
Chemomab Therapeutics’ CM-101 shows clinical potential in sclerosing cholangitis
3M ago
CMMB
Chemomab Therapeutics completes enrollment in Phase 2 trial of CM-101
PremiumThe FlyChemomab Therapeutics completes enrollment in Phase 2 trial of CM-101
4M ago
CMMB
Chemomab Therapeutics resumed with a Buy at Roth MKM
PremiumThe Fly
Chemomab Therapeutics resumed with a Buy at Roth MKM
4M ago
CMMB
Chemomab Therapeutics receives FDA Fast Track Designation for CM-101
PremiumThe Fly
Chemomab Therapeutics receives FDA Fast Track Designation for CM-101
5M ago
CMMB
Chemomab Therapeutics presents new data on CM-101, CCL24
PremiumThe Fly
Chemomab Therapeutics presents new data on CM-101, CCL24
5M ago
CMMB
Chemomab Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Chemomab Therapeutics files $200M mixed securities shelf
6M ago
CMMB
Chemomab Therapeutics initiated with a Buy at Roth MKM
PremiumThe Fly
Chemomab Therapeutics initiated with a Buy at Roth MKM
7M ago
CMMB
Palisade Bio appoints Jones as Chief Medical Officer
PremiumThe Fly
Palisade Bio appoints Jones as Chief Medical Officer
8M ago
CMMB
PALI
Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update
PremiumPress ReleasesChemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update
8M ago
CMMB
Chemomab announces publication of peer-reviewed article on CCL24
PremiumThe Fly
Chemomab announces publication of peer-reviewed article on CCL24
10M ago
CMMB
Chemomab Therapeutics presents data on PSC program at EASL 2023
PremiumThe Fly
Chemomab Therapeutics presents data on PSC program at EASL 2023
10M ago
CMMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >